GLP-1 receptor agonists are prescription medications that mimic this hormone which is why they lead to reduced appetite and, for many patients, significant weight loss
5, 11 CVD = cardiovascular disease, HF = heart failure, DKD = diabetic kidney disease, DKA = diabetic ketoacidosis Initiating funded treatment To initiate funded empagliflozin or GLP-1 receptor agonist treatment for type 2 diabetes, patients must meet the criteria outlined in Table 3
Every meal becomes an adventure
Frequency of administration varies by protocol
Management strategies include smaller frequent meals, texture modifications, adequate hydration, and gradual dose titration under medical supervision
Try these simple strategies to help your body stay balanced: Slow Down Support feelings of patience and calm with deep breathing, yoga, or time in nature